Malignant transformation in IgM monoclonal gammopathy of undetermined significance
- 30 April 2003
- journal article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 30 (2), 178-181
- https://doi.org/10.1053/sonc.2003.50067
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaJournal of Clinical Oncology, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Racial Differences in the Prevalence of Monoclonal Gammopathy in a Community-based Sample of the ElderlyThe American Journal of Medicine, 1998
- “Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-UpMayo Clinic Proceedings, 1993
- Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1992
- Evaluation of monoclonal gammopathies in the “well” elderlyThe American Journal of Medicine, 1987
- Monoclonal gammopathies in the adult population of Finistere, France.Journal of Clinical Pathology, 1982
- Smoldering Multiple MyelomaThe New England Journal of Medicine, 1980
- Monoclonal gammopathy of undetermined significance: Natural history in 241 casesThe American Journal of Medicine, 1978
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966